| 1 | The power of microRNAs as diagnostic and prognostic biomarkers in liquid biopsies显示文摘In the last decades,progresses in medical oncology have ameliorated the treatment of patients and their outcome.However,further improvements are still necessary,in particular for certain types of tumors such as pancreatic,gastric,and lung cancer as well as acute myeloid leukemia where early detection and monitoring of the disease are crucial for final patient outcome.Liquid biopsy represents a great advance in the field because it is less invasive,less time-consuming,and safer compared to classical biopsies and it can be useful to monitor the evolution of the disease as well as the response of patients to therapy.Liquid biopsy allows the detection of circulating tumor cells,nucleic acids,and exosomes not only in blood but also in different biological fluids:urine,saliva,pleural effusions,cerebrospinal fluid,and stool.Among the potential biomarkers detectable in liquid biopsies,microRNAs(miRNAs)are gaining more and more attention,since they are easily detectable,quite stable in biological fluids,and show high sensitivity.Many data demonstrate that miRNAs alone or in combination with other biomarkers could improve the diagnostic and prognostic power for many different tumors.Despite this,standardization of methods,sample preparation,and analysis remain challenging and a huge effort should be made to address these issues before miRNA biomarkers can enter the clinic.This review summarizes the main findings in the field of circulating miRNAs in both solid and hematological tumors. | Lorena Quirico Francesca Orso | 2020 | Cancer Drug Resistance2020，3，2： | 2 |
| 3 | Acute heart failure in the elderly:setting related differences in clinical features and management显示文摘BACKGROUND Administrative data show that acute heart failure(HF)patients are older than those enrolled in clinical registries and frequently admitted to non-cardiological settings of care.The purpose of this study was to describe clinical characteristics of old patients hospitalised for acute HF in Cardiology,Internal Medicine or Geriatrics wards.METHODS Data came from ATHENA(AcuTe Heart failurE in advaNced Age)registry which included elderly patients(≥65 years)admitted to the above mentioned settings of care from December 1,2014 to December 1,2015.RESULTS We enrolled 396 patients,15.4%assigned to Cardiology,69.7%to Internal Medicine,and 14.9%to a Geriatrics ward.Mean age was 83.5±7.6 years(51.8%of patients≥85 years)and was higher in patients admitted to Geriatrics(P<0.001);more than half were females.Medical treatments did not differ significantly among settings of care(in a context of a low prescription rate of renin-angiotensin-aldosterone system inhibitors)whereas significant differences were observed in comorbidity patterns and management guidelines recommendation adherence for decongestion evaluation with comparison of weight and N-terminal pro-B-type natriuretic peptide levels on admission and at discharge(both P=0.035 and P<0.001),echocardiographic evaluation(P<0.001)and follow-up visits planning(P<0.001),all higher in Cardiology.Mean in-hospital length of stay was 9±5.9 days,significantly higher in Geriatrics(13.7±6.5 days)and Cardiology(9.9±6.7 days)compared to Internal Medicine(8±5.2 days),P<0.001.In-hospital mortality was 9.3%,resulting higher in Geriatrics(18.6%)and Cardiology(16.4%)than Internal Medicine(5.8%),P=0.001.CONCLUSIONS In elderly patients hospitalised for acute HF,clinical characteristics and management differ significantly according to the setting of admission. | Francesco Orso Alessandra Pratesi Andrea Herbst Anna Chiara Baroncini Francesca Bacci Gabriele Ciuti Andrea Berni Camilla Tozzetti Carlo Nozzoli Alberto Moggi Pignone Loredana Poggesi Luciano Gabbani Mauro Di Bari Francesco Fattirolli Massimo Milli Andrea Ungar NiccolòMarchionni Samuele Baldasseroni | 2021 | Journal of Geriatric Cardiology2021，18，6： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员